Abstract |
Forty-five patients with virologically confirmed dendritic keratitis were treated in a randomized, double-blind controlled study with a basic therapy of trifluorothymidine (TFT) eye drops. In addition they received different human recombinant interferon (rHu IFN) eye drops. The following results were obtained for average healing times: TFT plus one drop daily of rHu IFN-alpha 2 arg (30 million iu/ml): 3.3 days, TFT plus rHu IFN-gamma (30 million iu/ml): 3.9 days, TFT plus a mixture of alpha plus gamma (0.3 million iu/ml each): 6.1 days, TFT plus a mixture of alpha plus gamma (1.5 million iu/ml each): 3.3 days. High-titer gamma interferon did not significantly differ from high-titer alpha interferon in the combination therapy of dendritic keratitis. A mixture of alpha plus gamma at a moderate titer (1.5 million iu/ml each) was as effective as a high-titer mono-preparation. Adding a low-titer interferon mixture gave no better therapeutic results than antiviral monotherapy. Thus it seems possible to save about 90% of interferon commonly used in the combination therapy of dendritic keratitis by applying a mixture of different suitable interferons instead of interferon monospecies.
|
Authors | R Sundmacher, A Mattes, D Neumann-Haefelin, G Adolf, B Kruss |
Journal | Current eye research
(Curr Eye Res)
Vol. 6
Issue 1
Pg. 273-6
(Jan 1987)
ISSN: 0271-3683 [Print] England |
PMID | 3030650
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Interferon Type I
- Interferon-gamma
|
Topics |
- Clinical Trials as Topic
- Conjunctiva
(microbiology)
- Cornea
(microbiology)
- Humans
- Interferon Type I
(therapeutic use)
- Interferon-gamma
(therapeutic use)
- Keratitis, Dendritic
(drug therapy)
- Simplexvirus
(isolation & purification)
- Therapeutic Irrigation
- Wound Healing
(drug effects)
|